Effects of Chicory and Fumitory products on hot flashes in breast cancer patients

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 64 人开始时间: 待定最近更新: 2021年6月21日

适应症

试验速览

暂无简介。

•Women between 18 and 65 years
•Breast cancer (stage 0-3)
•Having at least two hot flashes in 24 hours
•At least 4 weeks have elapsed since treatment with estrogen suppressive hormone therapy (Tamoxifen, LHRH agonists, Aromatase inhibitors)
•Estrogen suppressive hormone therapy continued unchanged until the end of the intervention

•Lack of informed consent to the plan
•Life expectancy is less than 6 months
•Having another cancer at the same time as breast cancer
•The patient is undergoing chemotherapy, radiotherapy or surgery
•Use of acupuncture and complementary medicine (hypnosis, psychotherapy)
•Taking antidepressants in the last 4 weeks
•Use of Anxiolytic drug, Gabapentin, Pregabalin, Clonidine, Aspirin, Vitamin E, Omega 3, Phytoestrogenic supplements
•Use of high phytoestrogenic diet
•Allergy to distillated of Chicory and Fumitory
•Kidney test (BUN,CR) is not in normal range
•Laboratory range Liver enzymes AST and ALT are more than twice the normal range
•Laboratory range and Total Bilirubin =2

发起方